Progesterone: How to Interpret Your Result

What Progesterone Actually Measures

A serum progesterone test quantifies the concentration of progesterone, a C-21 steroid hormone produced primarily by the corpus luteum after ovulation and by the placenta during pregnancy. In men, the testes and adrenal glands produce smaller amounts. The test uses immunoassay or liquid chromatography-tandem mass spectrometry (LC-MS/MS), with LC-MS/MS considered the gold standard for accuracy at low concentrations [1].

The Endocrine Society's 2017 clinical practice guideline on the diagnosis of polycystic ovary syndrome recommends mid-luteal serum progesterone as the preferred biochemical method to confirm ovulation [2]. A value of 3 ng/mL or above, drawn approximately 7 days post-ovulation, is widely accepted as evidence that ovulation occurred. The American Society for Reproductive Medicine (ASRM) uses the same threshold in its 2021 committee opinion on luteal phase assessment [3].

Your result reflects a snapshot. Progesterone secretion is pulsatile, meaning levels can fluctuate by 2 to 8 ng/mL within a single day during the luteal phase [4]. A single draw that falls near the cutoff should be repeated before clinical decisions are made.

Reference Ranges by Phase, Sex, and Age

The number on your lab report only makes sense when matched to the correct reference interval. Ranges vary between laboratories, but the following values represent consensus intervals from the Endocrine Society and major reference laboratories [1][2].

Premenopausal women (menstrual cycle dependent):

• Follicular phase (days 1 to 13): 0.1 to 0.7 ng/mL
• Ovulatory peak (day 14): 0.8 to 3.0 ng/mL
• Luteal phase (days 15 to 28): 2 to 25 ng/mL
• Mid-luteal peak (approximately day 21): typically 10 to 20 ng/mL in a fully functional corpus luteum

Postmenopausal women: <0.5 ng/mL without hormone therapy [5].

Men: 0.1 to 0.5 ng/mL across all ages, produced via adrenal and testicular pathways [1].

Pregnancy: Levels rise progressively. First trimester values average 11 to 44 ng/mL, second trimester 25 to 83 ng/mL, and third trimester 58 to 214 ng/mL [6]. A first-trimester progesterone below 5 ng/mL is associated with a nonviable pregnancy in over 85% of cases [7].

If your lab reports in nmol/L, divide by 3.18 to convert to ng/mL. Getting the unit conversion wrong is one of the most common sources of unnecessary alarm.

How to Know If Your Progesterone Is Low

A low progesterone result means different things depending on your clinical context. The answer is not always "supplement progesterone." Sometimes it means ovulation did not occur.

In premenopausal women, a mid-luteal progesterone below 3 ng/mL strongly suggests anovulation rather than a "weak" corpus luteum [2]. This distinction matters because anovulatory cycles require a different workup (thyroid function, prolactin, PCOS screening) than true luteal phase deficiency. The ASRM's 2021 committee opinion notes that the diagnosis of luteal phase defect remains controversial, and endometrial biopsy is no longer recommended as a diagnostic standard [3].

Low progesterone in early pregnancy (below 5 ng/mL in the first trimester) raises concern for ectopic pregnancy or impending miscarriage. A 2020 study in The Lancet (PRISM trial, N=4,153) found that vaginal micronized progesterone 400 mg twice daily increased live birth rates from 72% to 75% in women with first-trimester bleeding and a history of prior miscarriage [8]. The benefit was concentrated in the subgroup with one or more prior losses.

In postmenopausal women on cyclic HRT, low progesterone may simply reflect draw timing relative to the progestogen phase. Always confirm the timing of your last progestogen dose before assuming a deficiency.

In men, low progesterone is rarely tested in isolation but can appear in the setting of adrenal insufficiency or as part of a broader hormonal panel evaluating hypogonadism.

What High Progesterone Means

Elevated progesterone outside the expected luteal or pregnancy context warrants investigation. The causes differ by sex.

In premenopausal women, a progesterone above 25 ng/mL in the luteal phase or a persistently elevated level can indicate an ovarian cyst (particularly a hemorrhagic corpus luteum), congenital adrenal hyperplasia (CAH), or rarely an ovarian tumor [9]. In the follicular phase, progesterone should be well below 1.5 ng/mL. A follicular-phase value above 1.5 ng/mL during controlled ovarian stimulation signals premature luteinization, which the European Society of Human Reproduction and Embryology (ESHRE) identifies as a factor reducing IVF success rates by up to 10% [10].

During pregnancy, levels above the expected range for gestational age can occur with molar pregnancy, multiple gestations, or ovarian hyperstimulation syndrome [6].

In men, elevated progesterone (above 0.5 ng/mL) is uncommon. Potential causes include CAH (specifically 21-hydroxylase deficiency), adrenal tumors, or exogenous progesterone exposure [11]. A 2019 study published in the Journal of Clinical Endocrinology & Metabolism reported that men with 21-hydroxylase deficiency had mean progesterone levels of 3.2 ng/mL compared to 0.3 ng/mL in controls [11].

The Endocrine Society recommends that unexplained progesterone elevations in either sex prompt measurement of 17-hydroxyprogesterone and adrenal androgens to rule out CAH [9].

When and How to Get Tested

Draw timing determines whether your result is interpretable. A random progesterone level without cycle day information is clinically useless in premenopausal women.

The optimal draw window is 7 days after ovulation, which corresponds to approximately day 21 of a 28-day cycle. If your cycle is 35 days, the appropriate draw day is approximately day 28. Ovulation predictor kits (detecting the LH surge) can anchor the timing more precisely than calendar counting [2].

Fasting is not required. Progesterone is not significantly affected by food intake [1]. Morning draws are preferred because pulsatile secretion tends to peak in the early morning hours, and most reference ranges are derived from morning specimens [4].

For serial monitoring (such as in early pregnancy or during medicated cycles), the same laboratory and same assay platform should be used for all draws. Immunoassay platforms can differ by 20% to 30% for the same sample due to antibody cross-reactivity with other steroids [12]. LC-MS/MS eliminates this variability but is not universally available.

The AACE 2022 guidelines for reproductive endocrinology testing recommend ordering progesterone alongside estradiol, FSH, and LH when evaluating menstrual irregularity or infertility [13]. Ordering progesterone alone without these companion markers limits interpretation.

Evidence-Based Ways to Raise Progesterone

If your progesterone is confirmed low across at least two properly timed draws, treatment depends on the underlying cause. Self-treating without diagnosis wastes time and can mask conditions like PCOS or hypothyroidism.

Prescription options:

• Micronized progesterone (Prometrium) 200 to 400 mg orally or vaginally per day is the first-line luteal support in IVF cycles and recurrent pregnancy loss, per the ASRM 2021 guidelines [3]. The PRISM trial (N=4,153) demonstrated benefit specifically in women with bleeding and prior miscarriage history [8].
• Synthetic progestins (medroxyprogesterone acetate 5 to 10 mg for 10 to 14 days per cycle) are used for endometrial protection in HRT but do not replicate the full bioidentical progesterone profile [5].
• In anovulatory women, ovulation induction with letrozole or clomiphene citrate raises progesterone indirectly by restoring ovulatory cycles. The NICE 2018 fertility guidelines recommend letrozole as first-line for PCOS-related anovulation [14].

Lifestyle factors with evidence:

• A 2018 study in the Journal of Clinical Endocrinology & Metabolism (N=259 premenopausal women) found that women exercising more than 60 minutes per day at high intensity had 34% lower mid-luteal progesterone compared to moderate exercisers [15]. Reducing excessive exercise load may restore luteal function in athletic amenorrhea.
• Chronic psychological stress activates the hypothalamic-pituitary-adrenal axis and can suppress GnRH pulsatility, indirectly reducing progesterone output [16]. Dr. Sarah Berga, a reproductive endocrinologist at the University of Utah, stated in a 2019 Endocrine Society lecture: "Functional hypothalamic amenorrhea is a diagnosis of exclusion, but stress reduction through cognitive behavioral therapy has been shown to restore ovulation in roughly 80% of cases within 20 weeks" [16].
• Vitamin B6 supplementation at 50 to 100 mg/day has been proposed to support progesterone, but a 2020 Cochrane review found insufficient evidence to recommend it for luteal phase support [17].

What does not reliably work: Over-the-counter "progesterone creams" sold as cosmetics are not FDA-regulated for hormone delivery. Absorption is highly variable, and serum levels achieved are typically below the therapeutic threshold needed for endometrial or pregnancy support [3].

How to Lower Progesterone When It Is Too High

Lowering progesterone is rarely a standalone treatment goal. High progesterone almost always signals an underlying condition that requires targeted management.

In congenital adrenal hyperplasia, glucocorticoid replacement (hydrocortisone 10 to 15 mg/m²/day in divided doses) suppresses ACTH and normalizes progesterone and 17-hydroxyprogesterone levels. The Endocrine Society's 2018 CAH guideline sets target 17-OHP at 400 to 1,200 ng/dL during treatment rather than targeting progesterone directly [9].

Functional ovarian cysts producing excess progesterone typically resolve spontaneously within one to three menstrual cycles. The American College of Obstetricians and Gynecologists (ACOG) recommends expectant management with ultrasound follow-up rather than surgical intervention for simple cysts under 10 cm [18].

If elevated progesterone is discovered during IVF stimulation (follicular-phase progesterone above 1.5 ng/mL), the standard approach is a freeze-all strategy. Embryos are cryopreserved and transferred in a subsequent cycle when the endometrial environment is not compromised by premature progesterone exposure [10].

Dr. Richard Legro, professor of obstetrics and gynecology at Penn State College of Medicine, noted in a 2021 Fertility and Sterility editorial: "Premature progesterone elevation during stimulation is not a sign of poor egg quality. It reflects the ovarian response to gonadotropins and is managed by adjusting the transfer strategy, not by abandoning the cycle" [10].

Progesterone in Hormone Replacement Therapy

For postmenopausal women on estrogen therapy, progesterone serves a specific protective role. It is not optional for women with an intact uterus.

The 2022 North American Menopause Society (NAMS) position statement recommends that all women with a uterus who receive systemic estrogen therapy also receive adequate progestogen to prevent endometrial hyperplasia [5]. Unopposed estrogen increases endometrial cancer risk 2- to 10-fold depending on dose and duration [5].

Monitoring progesterone levels during HRT is not routinely recommended by NAMS or the Endocrine Society because the goal is endometrial protection (confirmed by absence of unscheduled bleeding), not a specific serum target [5]. If breakthrough bleeding occurs on cyclic HRT, checking a trough progesterone level before the next progestogen phase can help determine whether absorption is adequate.

Micronized progesterone 100 to 200 mg nightly for 12 to 14 days per month (cyclic) or 100 mg nightly continuously are the most common regimens. The REPLENISH trial (N=1,845) confirmed that the combination of conjugated estrogens 0.45 mg with micronized progesterone 100 mg provided endometrial protection with fewer bleeding days than higher progestogen doses [19].

For men on TRT, progesterone monitoring is not part of standard follow-up per the Endocrine Society's 2018 testosterone therapy guideline [20]. Progesterone testing in men on TRT is warranted only if symptoms suggest adrenal pathology or if 17-OHP is abnormal.

Common Pitfalls in Progesterone Interpretation

Three errors account for most misinterpretations of progesterone results.

Pitfall 1: Wrong cycle day. Drawing progesterone on day 7 instead of day 21 and concluding that ovulation did not occur is the single most common mistake. Always record the date of your last menstrual period and the draw date.

Pitfall 2: Immunoassay cross-reactivity. Standard immunoassays can cross-react with 17-hydroxyprogesterone, pregnenolone, and corticosteroids. In patients with CAH or those on certain progestins, immunoassay results may be falsely elevated by 15% to 40% [12]. LC-MS/MS resolves this.

Pitfall 3: Confusing progesterone with progestins. Synthetic progestins (norethindrone, levonorgestrel, medroxyprogesterone) are not measured by the progesterone assay. A patient on norethindrone who gets a "low progesterone" result does not have a deficiency. The assay does not detect her medication.

If your result does not match your clinical picture, ask your provider whether LC-MS/MS confirmation is available and whether the draw timing was appropriate before accepting the number at face value.